title: Pharmacological effects of melatonin on reproductive activity: experimental bioimplants with sustained-release polymeric systems.
abstract: A vast literature documents the role of melatonin in human reproductive function including: a) the relation between melatonin and the menstrual cycle in relation to the peak time of luteinizing hormone in the middle of the cycle; b) the varying concentrations of melatonin in the control of puberty; c) the fewer conceptions in some artic populations where melatonin is connected significantly to seasonal photoperiodicity during the months of the polar nights. The aim of this paper is to report our findings on the pharmacological action of this molecule on reproduction in which gonadal activity is clearly connected to photoperiodicity. We used polymer bioimplants programmed for the sustained release of melatonin for experimental gynecologic protocols. These implants had beneficial results with respect to the use of progestinics because melatonin allowed ovarian activity to be induced for at least two to three consecutive cycles with one single bioimplant. We thought it indispensable to use pharmacological systems with a sustained release because different preliminary tests showed that the half-life of melatonin is limited at maximum to two to three hours and, consequently, any other tested modalities of administration would not provide any appreciable results for our study. As a model for our research we used goats to administer melatonin via targeted programs since these animals clearly respond (even against the rule of the light/dark relation) in contrast to humans in whom response is less evident. For controls, after inserting bioimplants in the animals, we tested their efficiency in vitro and subsequently in vivo, evaluating blood parameters and pharmacological effects of melatonin occurring during the treatment. The final results proved to be interesting in relation to reproductive activity in that regular and programmed births were achieved.
authors.affiliation: University of Messina, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Tripodi
authors.forename: A
authors.initials: A
authors.lastname: Tripodi
authors.forename: C
authors.initials: C
authors.lastname: Mammì
authors.forename: C
authors.initials: C
authors.lastname: Pullè
authors.forename: A
authors.initials: A
authors.lastname: Pecile
authors.forename: F
authors.initials: F
authors.lastname: Cremonesi
mesh_terms: D020341:Absorbable Implants; D000818:Animals; D003692:Delayed-Action Preparations; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006041:Goats / Q000502:physiology*; D008550:Melatonin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D011247:Pregnancy; D018873:Pregnancy Rate; D012098:Reproduction / Q000187:drug effects*
chemical_list: D003692:Delayed-Action Preparations; D005300:Fertility Agents, Female; D008550:Melatonin